NASDAQ:CRON Cronos Group - CRON Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $2.49 -0.09 (-3.49%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.49▼$2.5750-Day Range$2.42▼$3.5052-Week Range$2.39▼$4.31Volume1.53 million shsAverage Volume1.53 million shsMarket Capitalization$947.40 millionP/E RatioN/ADividend YieldN/APrice Target$4.21 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Cronos Group MarketRank™ ForecastAnalyst RatingModerate Buy2.57 Rating ScoreUpside/Downside69.2% Upside$4.21 Price TargetShort InterestBearish3.98% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.48Based on 2 Articles This WeekInsider TradingAcquiring Shares$1.30 M Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.29) to ($0.19) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.87 out of 5 starsMedical Sector694th out of 1,029 stocksMedicinals & Botanicals Industry9th out of 15 stocks 3.3 Analyst's Opinion Consensus RatingCronos Group has received a consensus rating of Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.21, Cronos Group has a forecasted upside of 69.2% from its current price of $2.49.Amount of Analyst CoverageCronos Group has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.98% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in Cronos Group has recently increased by 0.13%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRON. Previous Next 0.8 News and Social Media Coverage News SentimentCronos Group has a news sentiment score of -0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cronos Group this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,302,605.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 5.95% of the stock of Cronos Group is held by insiders.Percentage Held by InstitutionsOnly 11.94% of the stock of Cronos Group is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Cronos Group are expected to grow in the coming year, from ($0.29) to ($0.19) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is -4.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is -4.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Cronos Group (NASDAQ:CRON) StockCronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.Read More Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CRON Stock News HeadlinesJanuary 30, 2023 | msn.comAltria Group Stock: Bull vs. BearJanuary 29, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Materials Companies: Archer Daniels Midland (ADM) and Cronos Group (CRON)February 3, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 27, 2023 | americanbankingnews.comCronos Group (NASDAQ:CRON) Sets New 52-Week Low at $2.39January 25, 2023 | marketwatch.comCronos Group Inc. stock remains steady Wednesday, still outperforms marketJanuary 25, 2023 | americanbankingnews.comCronos Group Inc. (NASDAQ:CRON) Sees Significant Increase in Short InterestJanuary 22, 2023 | morningstar.comCronos Group Inc CRON Stock QuoteJanuary 19, 2023 | msn.com'Youth Oriented' Labels, Lack Of Regulation To Blame For Child Marijuana PoisoningsFebruary 3, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! January 17, 2023 | marketwatch.comLegalized Canabis Market Size 2023 with Over-all Dominated, Share of Everywhere, Ease of Access of SolutionsDecember 26, 2022 | finance.yahoo.comCryptocurrencies To Watch: Week of December 26December 19, 2022 | proactiveinvestors.comAltria Group relinquishes warrant which could have led to increased stake in Cronos GroupDecember 19, 2022 | marketwatch.comCronos Shares Fall 4% After Altria Abandons Warrant Upping StakeDecember 19, 2022 | benzinga.comAltria Abandons Expiring Cronos Warrant, Maintains Initial InvestmentDecember 19, 2022 | finance.yahoo.comCronos Group Inc. Announces Receipt of Notice of Relinquishment of Warrant by AltriaDecember 7, 2022 | benzinga.comCronos Launches Spinach FEELZ Day Trip Gummies With THC And CBCDecember 6, 2022 | baystreet.caEquities Bruised Ahead of BoC DecisionNovember 25, 2022 | marketwatch.comCBD-infused Cosmetics Market 2023 : Projected to Deliver Greater Revenues during the Forecast Period 2028November 22, 2022 | finance.yahoo.comHere's Why I'm Closing My Crypto.Com Account in 2023November 16, 2022 | finance.yahoo.comWhy Cardano, Chainlink, and Cronos Are Slumping TodayNovember 14, 2022 | finance.yahoo.comMatt Damon Crypto.com's Coin Is in Free FallNovember 14, 2022 | finance.yahoo.comCrypto.com’s Sinking Token Stirs Fresh Anxiety After FTX WipeoutNovember 14, 2022 | finance.yahoo.comCronos Group Appoints James Holm as Chief Financial OfficerNovember 14, 2022 | finance.yahoo.comCannabis-focused Scotts Miracle-Gro, Cronos both hire new chief financial officersNovember 8, 2022 | seekingalpha.comCronos Group: There Are Green Shoots Amid The WeedsNovember 7, 2022 | finance.yahoo.comCronos Group (CRON) Reports Q3 Loss, Misses Revenue EstimatesNovember 7, 2022 | marketwatch.comCronos Swings to Loss in 3Q as Revenue Growth Misses ViewsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CRON Company Calendar Last Earnings11/07/2022Today2/03/2023Next Earnings (Estimated)3/07/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CRON CUSIPN/A CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees626Year FoundedN/APrice Target and Rating Average Stock Price Forecast$4.21 High Stock Price Forecast$7.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+69.2%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-396,110,000.00 Net Margins-235.72% Pretax Margin-234.01% Return on Equity-16.29% Return on Assets-15.66% Debt Debt-to-Equity RatioN/A Current Ratio25.37 Quick Ratio24.47 Sales & Book Value Annual Sales$74.43 million Price / Sales12.73 Cash FlowN/A Price / Cash FlowN/A Book Value$3.56 per share Price / Book0.70Miscellaneous Outstanding Shares380,480,000Free Float357,838,000Market Cap$947.40 million OptionableOptionable Beta1.52 Key ExecutivesMichael Ryan GorensteinChairman, President & Chief Executive OfficerJames HolmChief Financial OfficerArye WeigensbergVice President-Research & TechnologyJeffrey JacobsonSenior VP, Head-Growth-North AmericaShannon BuggySenior Vice President & Global Head-PeopleKey CompetitorsUSANA Health SciencesNYSE:USNASNDLNASDAQ:SNDLCanopy GrowthNASDAQ:CGCAurora CannabisNYSE:ACBbioteNASDAQ:BTMDView All CompetitorsInsiders & InstitutionsSimplex Trading LLCSold 656,100 shares on 2/2/2023Ownership: 0.000%Janney Montgomery Scott LLCSold 8,169 shares on 2/1/2023Ownership: 0.059%Zurcher Kantonalbank Zurich Cantonalbank Bought 17,449 shares on 2/1/2023Ownership: 0.014%National Bank of Canada FIBought 81,689 shares on 1/24/2023Ownership: 0.026%Johnson & White Wealth Management LLCBought 11,584 shares on 1/18/2023Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions CRON Stock - Frequently Asked Questions Should I buy or sell Cronos Group stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CRON shares. View CRON analyst ratings or view top-rated stocks. What is Cronos Group's stock price forecast for 2023? 7 Wall Street analysts have issued 12 month target prices for Cronos Group's shares. Their CRON share price forecasts range from $3.00 to $7.00. On average, they predict the company's share price to reach $4.21 in the next year. This suggests a possible upside of 65.3% from the stock's current price. View analysts price targets for CRON or view top-rated stocks among Wall Street analysts. How have CRON shares performed in 2023? Cronos Group's stock was trading at $2.54 on January 1st, 2023. Since then, CRON shares have increased by 0.4% and is now trading at $2.55. View the best growth stocks for 2023 here. When is Cronos Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023. View our CRON earnings forecast. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) posted its earnings results on Monday, November, 7th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The business earned $20.92 million during the quarter, compared to analysts' expectations of $23.30 million. Cronos Group had a negative net margin of 235.72% and a negative trailing twelve-month return on equity of 16.29%. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and Organigram (OGI). What is Cronos Group's stock symbol? Cronos Group trades on the NASDAQ under the ticker symbol "CRON." Who are Cronos Group's major shareholders? Cronos Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Simplex Trading LLC (0.00%), Janney Montgomery Scott LLC (0.06%), National Bank of Canada FI (0.03%), Zurcher Kantonalbank Zurich Cantonalbank (0.01%), Bank of Montreal Can (0.00%) and Johnson & White Wealth Management LLC (0.00%). Insiders that own company stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham. View institutional ownership trends. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cronos Group's stock price today? One share of CRON stock can currently be purchased for approximately $2.55. How much money does Cronos Group make? Cronos Group (NASDAQ:CRON) has a market capitalization of $970.22 million and generates $74.43 million in revenue each year. The company earns $-396,110,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis. How many employees does Cronos Group have? The company employs 626 workers across the globe. How can I contact Cronos Group? Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at (416) 504-0004. This page (NASDAQ:CRON) was last updated on 2/3/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.